About 129,000 results
Open links in new tab
Novartis Kisqali® shows deepening benefit in new analysis, …
FDA approves Novartis Kisqali® to reduce risk of recurrence in …
FDA approves Novartis Kisqali® to reduce risk of recurrence in …
FDA approves Novartis Kisqali® to reduce risk of recurrence in …
FDA approves Novartis Kisqali® to reduce risk of recurrence in …
FDA expands approval of breast cancer drug Kisqali - NBC New York
Novartis Wins FDA Approval of Kisqali for Early Breast Cancer
Latest analysis of Novartis NATALEE study shows Kisqali® …
Novartis’ Kisqali receives FDA approval to reduce the risk of …
FDA expands Novartis’ Kisqali label to include early breast cancer …